Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

An 11-year minimum follow-up of the Charite III lumbar disc replacement for the treatment of symptomatic degenerative disc disease

An 11-year minimum follow-up of the Charite III lumbar disc replacement for the treatment of... Eur Spine J (2015) 24:2056–2064 DOI 10.1007/s00586-015-3939-5 ORIGINAL ARTICLE An 11-year minimum follow-up of the Charite III lumbar disc replacement for the treatment of symptomatic degenerative disc disease 1 1 1 1 1 • • • • • Shi-bao Lu Yong Hai Chao Kong Qing-yi Wang Qingjun Su 1 1 1 1 • • • Lei Zang Nan Kang Xiang-long Meng Yu Wang Received: 16 August 2014 / Revised: 6 April 2015 / Accepted: 6 April 2015 / Published online: 21 April 2015 The Author(s) 2015. This article is published with open access at Springerlink.com Abstract 13.8 years. Twenty-eight patients (87.5 %) had a success- Purpose To report our 11-year minimum clinical and ful outcome, as defined by the FDA. Reoperation was radiological outcomes, as well as complications of the performed in 2 patients for adjacent segment degeneration Charite III total disc replacement (TDR). and pedicle fracture (1 case each). Both VAS and ODI Methods A total of 35 patients indicated for total disc scores showed significant improvement compared to replacement were implanted with the Charite III prosthesis. baseline. At the final follow-up, the ROM of both the in- Clinical evaluation included visual analog scale (VAS) for dex- and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Spine Journal Springer Journals

An 11-year minimum follow-up of the Charite III lumbar disc replacement for the treatment of symptomatic degenerative disc disease

Download PDF
9 pages

 
/lp/springer-journals/an-11-year-minimum-follow-up-of-the-charite-iii-lumbar-disc-dXHWntkPGk

References (48)

Publisher
Springer Journals
Copyright
Copyright © 2015 by The Author(s)
Subject
Medicine & Public Health; Surgical Orthopedics; Neurosurgery
ISSN
0940-6719
eISSN
1432-0932
DOI
10.1007/s00586-015-3939-5
pmid
25895882
Publisher site
See Article on Publisher Site

Abstract

Eur Spine J (2015) 24:2056–2064 DOI 10.1007/s00586-015-3939-5 ORIGINAL ARTICLE An 11-year minimum follow-up of the Charite III lumbar disc replacement for the treatment of symptomatic degenerative disc disease 1 1 1 1 1 • • • • • Shi-bao Lu Yong Hai Chao Kong Qing-yi Wang Qingjun Su 1 1 1 1 • • • Lei Zang Nan Kang Xiang-long Meng Yu Wang Received: 16 August 2014 / Revised: 6 April 2015 / Accepted: 6 April 2015 / Published online: 21 April 2015 The Author(s) 2015. This article is published with open access at Springerlink.com Abstract 13.8 years. Twenty-eight patients (87.5 %) had a success- Purpose To report our 11-year minimum clinical and ful outcome, as defined by the FDA. Reoperation was radiological outcomes, as well as complications of the performed in 2 patients for adjacent segment degeneration Charite III total disc replacement (TDR). and pedicle fracture (1 case each). Both VAS and ODI Methods A total of 35 patients indicated for total disc scores showed significant improvement compared to replacement were implanted with the Charite III prosthesis. baseline. At the final follow-up, the ROM of both the in- Clinical evaluation included visual analog scale (VAS) for dex- and

Journal

European Spine Journal – Springer Journals

Published: Apr 21, 2015

There are no references for this article.